苏威孚B(200581):2023年半年度财务报告(英文版)
|
时间:2023年08月21日 18:11:29 中财网 |
|
原标题:苏威孚B:2023年半年度财务报告(英文版)
WEIFU HIGH-TECHNOLOGY GROUP CO., LTD.
Semi-Annual Financial Reprot 2023
(Unaudited)
August 2023
I. Audit report
Whether the semi annual report is audited or not
□Yes ?No
The company's semi annual financial report has not been audited II. Financial Statement
Statement in Financial Notes are carried in RMB/CNY
1. Consolidated Balance Sheet
Prepared by Weifu High-Technology Group Co., Ltd.
June 30, 2023
In RMB
Item | June 30, 2023 | January 1, 2023 | Current assets: | | | Monetary funds | 2,487,786,142.04 | 2,389,551,930.76 | Settlement provisions | | | Capital lent | | | Trading financial assets | 2,250,198,464.28 | 2,718,820,654.87 | Derivative financial assets | | | Note receivable | 104,980,712.30 | 135,559,024.27 | Account receivable | 3,317,387,077.56 | 3,127,490,177.25 | Receivable financing | 1,920,348,206.04 | 1,918,368,845.21 | Prepayments | 67,710,664.23 | 94,323,853.87 | Insurance receivable | | | Reinsurance receivables | | | Contract reserve of reinsurance receivable | | | Other account receivable | 2,874,547,071.97 | 1,264,507,456.47 | Including: Interest receivable | | | Dividend receivable | 1,955,605,474.71 | 147,000,000.00 | Buying back the sale of financial assets | | | Inventory | 1,921,084,065.82 | 2,283,119,656.27 | Contract assets | | | Assets held for sale | | | Non-current asset due within 1 year | | | Other current assets | 240,962,367.80 | 430,547,201.24 | Total current assets | 15,185,004,772.04 | 14,362,288,800.21 | Non-current assets: | | | Loans and payments on behalf | | | Debt investment | | | Other debt investment | | | Long-term account receivable | | | Long-term equity investment | 5,187,995,234.43 | 6,282,818,108.96 | Other equity instrument investment | 677,790,690.00 | 677,790,690.00 | Other non-current financial assets | 1,166,342,387.00 | 1,326,608,914.00 | Investment real estate | 56,185,135.36 | 49,296,869.73 | Fixed assets | 3,745,590,665.96 | 3,769,984,185.94 | Construction in progress | 639,963,756.99 | 509,105,587.49 | Productive biological assets | | | Oil and gas assets | | | Right-of-use assets | 39,364,840.80 | 41,865,100.38 | Intangible assets | 489,758,310.65 | 487,627,987.92 | Expense on research and development | | | Goodwill | 251,813,115.66 | 237,682,375.72 | Long-term expenses to be apportioned | 27,143,337.26 | 28,586,235.84 | Deferred income tax assets | 273,908,331.15 | 275,627,772.45 | Other non-current assets | 611,808,088.23 | 479,630,436.37 | Total non-current assets | 13,167,663,893.49 | 14,166,624,264.80 | Total assets | 28,352,668,665.53 | 28,528,913,065.01 | Current liabilities: | | | Short-term loans | 2,256,900,925.45 | 3,604,376,527.82 | Loans from central bank | | | Capital borrowed | | | Trading financial liabilities | | | Derivative financial liabilities | 737,424.50 | 747,115.75 | Note payable | 1,584,124,651.19 | 1,411,089,606.00 | Account payable | 3,271,926,231.00 | 3,454,601,023.60 | Advance payment | 462,221.88 | 3,633,878.33 | Contractual liabilities | 104,491,724.54 | 94,850,083.23 | Selling financial asset of repurchase | | | Absorbing deposit and interbank deposit | | | Security trading of agency | | | Security sales of agency | | | Wage payable | 225,684,651.78 | 317,434,386.24 | Taxe payable | 64,158,658.16 | 54,586,315.53 | Other account payable | 156,729,445.68 | 198,990,948.23 | Including: Interest payable | | | Dividend payable | 10,373,454.00 | | Commission charge and commission payable | | | Reinsurance payable | | | Liabilities held for sale | | | Non-current liabilities due within 1 year | 36,959,064.67 | 14,285,348.90 | Other current liabilities | 262,650,217.54 | 211,763,779.77 | Total current liabilities | 7,964,825,216.39 | 9,366,359,013.40 | Non-current liabilities: | | | Insurance contract reserve | | | Long-term loans | 600,000,000.00 | 238,000,000.00 | Bond payable | | | Including: Preferred stock | | | Perpetual capital securities | | | Lease liabilities | 30,799,799.49 | 31,589,277.20 | Long-term account payable | 30,785,082.11 | 30,785,082.11 | Long-term wage payable | 155,985,385.60 | 154,093,044.28 | Accrual liabilities | 9,980,678.92 | 10,106,268.87 | Deferred income | 199,209,771.05 | 223,123,978.78 | Deferred income tax liabilities | 39,772,528.51 | 40,149,550.99 | Other non-current liabilities | | | Total non-current liabilities | 1,066,533,245.68 | 727,847,202.23 | Total liabilities | 9,031,358,462.07 | 10,094,206,215.63 | Owner’s equity: | | | Share capital | 1,002,579,793.00 | 1,008,603,293.00 | Other equity instrument | | | Including: Preferred stock | | | Perpetual capital securities | | | Capital reserve | 3,335,177,095.84 | 3,398,368,567.63 | Less: Inventory shares | 538,410,272.24 | 541,623,002.63 | Other comprehensive income | 60,328,251.06 | -911,310.13 | Reasonable reserve | 3,583,407.75 | 2,119,800.95 | Surplus reserve | 510,100,496.00 | 510,100,496.00 | Provision of general risk | | | Retained profit | 14,171,024,206.15 | 13,320,021,325.90 | Total owner’ s equity attributable to parent company | 18,544,382,977.56 | 17,696,679,170.72 | Minority interests | 776,927,225.90 | 738,027,678.66 | Total owner’ s equity | 19,321,310,203.46 | 18,434,706,849.38 | Total liabilities and owner’ s equity | 28,352,668,665.53 | 28,528,913,065.01 |
Legal Representative: Wang Xiaodong
Person in charge of accounting works: Rong Bin Person in charge of accounting institute: Wu Junfei
2. Balance sheet of parent company
Item | June 30, 2023 | January 1, 2023 | Current assets: | | | Monetary funds | 658,847,374.34 | 823,574,329.53 | Trading financial assets | 2,134,459,399.76 | 2,693,150,975.20 | Derivative financial assets | | | Note receivable | 38,585,991.52 | 29,575,852.04 | Account receivable | 1,106,215,964.34 | 906,808,283.22 | Receivable financing | 231,837,502.28 | 216,462,262.44 | Prepayments | 38,880,788.18 | 56,037,892.68 | Other account receivable | 3,206,692,791.69 | 1,472,102,439.27 | Including: Interest receivable | 32,195,758.91 | 206,325.34 | Dividend receivable | 1,881,769,939.06 | | Inventories | 554,131,949.66 | 571,571,431.95 | Contract assets | | | Assets held for sale | | | Non-current assets maturing within 1 year | | | Other current assets | 1,755,265.16 | 107,462,112.82 | Total current assets | 7,971,407,026.93 | 6,876,745,579.15 | Non-current assets: | | | Debt investment | | | Other debt investment | | | Long-term account receivable | | | Long-term equity investment | 7,290,721,357.80 | 8,369,843,351.10 | Other equity instrument investment | 601,850,690.00 | 601,850,690.00 | Other non-current financial assets | 1,166,342,387.00 | 1,326,608,914.00 | Investment real estate | 35,018,863.59 | 35,584,279.11 | Fixed assets | 2,232,822,699.74 | 2,251,495,050.80 | Construction in progress | 344,391,742.48 | 251,304,655.41 | Productive biological assets | | | Oil and natural gas assets | | | Right-of-use assets | 4,321,883.64 | 6,061,693.75 | Intangible assets | 211,423,280.19 | 209,246,490.17 | Research and development costs | | | Goodwill | | | Long-term deferred expenses | 6,417,238.81 | 6,895,352.43 | Deferred income tax assets | 88,907,446.28 | 109,624,761.50 | Other non-current assets | 222,124,598.31 | 168,744,695.04 | Total non-current assets | 12,204,342,187.84 | 13,337,259,933.31 | Total assets | 20,175,749,214.77 | 20,214,005,512.46 | Current liabilities | | | Short-term loans | 1,461,515,277.78 | 2,121,354,415.53 | Trading financial liabilities | | | Derivative financial liabilities | 737,424.50 | 737,424.50 | Note payable | 332,041,918.11 | 251,867,652.05 | Account payable | 1,103,757,868.99 | 1,048,268,519.52 | Advance payment | | | Contract liabilities | 8,032,872.19 | 6,564,332.93 | Wage payable | 106,415,365.78 | 166,314,985.33 | Taxe payable | 16,561,316.90 | 6,048,505.30 | Other account payable | 431,093,918.61 | 926,276,130.15 | Including: Interest payable | 1,369,121.16 | 835,069.83 | Dividend payable | 10,373,454.00 | | Liabilities held for sale | | | Non-current liabilities due within 1 year | 28,238,743.21 | 4,306,935.71 | Other current liabilities | 85,179,531.11 | 102,322,311.03 | Total current liabilities | 3,573,574,237.18 | 4,634,061,212.05 | Non-current liabilities: | | | Long-term loans | 400,000,000.00 | | Bond payable | | | Including: preferred stock | | | Perpetual capital securities | | | Lease liabilities | 3,044,575.55 | 2,690,812.43 | Long-term account payable | | | Long term employee compensation payable | 121,683,760.89 | 121,683,760.89 | Accrued liabilities | | 13,750.00 | Deferred income | 169,822,415.83 | 198,149,511.20 | Deferred income tax liabilities | | | Other non-current liabilities | | | Total non-current liabilities | 694,550,752.27 | 322,537,834.52 | Total liabilities | 4,268,124,989.45 | 4,956,599,046.57 | Owners’ equity: | | | Share capital | 1,002,579,793.00 | 1,008,603,293.00 | Other equity instrument | | | Including: preferred stock | | | Perpetual capital securities | | | Capital reserve | 3,451,969,145.81 | 3,515,005,861.23 | Less: Inventory shares | 538,410,272.24 | 541,623,002.63 | Other comprehensive income | | | Special reserve | | | Surplus reserve | 510,100,496.00 | 510,100,496.00 | Retained profit | 11,481,385,062.75 | 10,765,319,818.29 | Total owner’s equity | 15,907,624,225.32 | 15,257,406,465.89 | Total liabilities and owner’s equity | 20,175,749,214.77 | 20,214,005,512.46 |
1. Consolidated profit statement
In RMB
Item | 2023 semi-annual | 2022 semi-annual | I. Total operating income | 6,129,649,047.40 | 7,137,172,857.97 | Including: Operating income | 6,129,649,047.40 | 7,137,172,857.97 | Interest income | | | Insurance gained | | | Commission charge and commission income | | | II. Total operating cost | 5,988,688,585.81 | 6,730,969,892.10 | Including: Operating cost | 5,163,871,731.26 | 6,026,454,182.03 | Interest expense | | | Commission charge and commission expense | | | Cash surrender value | | | Net amount of expense of compensation | | | Net amount of withdrawal of insurance contract reserve | | | Bonus expense of guarantee slip | | | Reinsurance expense | | | Tax and extra | 32,240,422.99 | 28,877,421.78 | Sales expense | 103,031,481.40 | 79,020,592.43 | Administrative expense | 299,195,729.59 | 277,212,254.79 | R&D expense | 351,887,038.12 | 289,631,376.50 | Financial expense | 38,462,182.45 | 29,774,064.57 | Including: Interest expenses | 65,616,425.64 | 34,275,262.65 | Interest income | 15,706,416.56 | 13,927,929.36 | Add: other income | 40,979,593.51 | 26,095,621.93 | Investment income (Loss is listed with “-”) | 811,406,633.49 | 928,792,343.97 | Including: Investment income on affiliated company and joint
venture | 742,783,514.37 | 823,400,731.10 | The termination of income recognition for financial assets
measured by amortized cost | | -680,357.44 | Exchange income (Loss is listed with “-”) | | | Net exposure hedging income (Loss is listed with “-”) | | | Income from change of fair value (Loss is listed with “-”) | -18,069,553.29 | -74,432,928.14 | Loss of credit impairment (Loss is listed with “-”) | -846,725.76 | 2,083,427.81 | Loss of devaluation of asset (Loss is listed with “-”) | -90,263,537.00 | -104,219,783.98 | Income from assets disposal (Loss is listed with “-”) | 125,530,905.04 | 1,890,279.95 | III. Operating profit (Loss is listed with “-”) | 1,009,697,777.58 | 1,186,411,927.41 | Add: Non-operating income | 2,707,696.00 | 218,285.29 | Less: Non-operating expense | 758,381.69 | 2,196,565.87 | IV. Total profit (Loss is listed with “-”) | 1,011,647,091.89 | 1,184,433,646.83 | Less: Income tax expense | 29,332,279.74 | 55,645,075.75 | V. Net profit (Net loss is listed with “-”) | 982,314,812.15 | 1,128,788,571.08 | (i) Classify by business continuity | | | 1. Continuous operating net profit (net loss listed with “-”) | 982,314,812.15 | 1,128,788,571.08 | 2. Termination of net profit (net loss listed with “-”) | | | (ii) Classify by ownership | | | 1. Net profit attributable to owner’s of parent company | 948,760,859.55 | 1,091,126,480.08 | 2. Minority shareholders’ gains and losses | 33,553,952.60 | 37,662,091.00 | VI. Net after-tax of other comprehensive income | 61,239,561.19 | -12,679,652.16 | Net after-tax of other comprehensive income attributable to owners of
parent company | 61,239,561.19 | -12,679,652.16 | (i) Other comprehensive income items which will not be reclassified
subsequently to profit of loss | -305,484.37 | | 1. Changes of the defined benefit plans that re-measured | -305,484.37 | | 2. Other comprehensive income under equity method that cannot be
transfer to gain/loss | | | 3. Change of fair value of other equity instrument investment | | | 4. Fair value change of enterprise's credit risk | | | 5. Other | | | (ii) Other comprehensive income items which will be reclassified
subsequently to profit or loss | 61,545,045.56 | -12,679,652.16 | 1. Other comprehensive income under equity method that can transfer
to gain/loss | | | 2. Change of fair value of other debt investment | | | 3. Amount of financial assets re-classify to other comprehensive
income | | | 4. Credit impairment provision for other debt investment | | | 5. Cash flow hedging reserve | | | 6. Translation differences arising on translation of foreign currency
financial statements | 61,545,045.56 | -12,679,652.16 | 7. Other | | | Net after-tax of other comprehensive income attributable to minority
shareholders | | | VII. Total comprehensive income | 1,043,554,373.34 | 1,116,108,918.92 | Total comprehensive income attributable to owners of parent
Company | 1,010,000,420.74 | 1,078,446,827.92 | Total comprehensive income attributable to minority shareholders | 33,553,952.60 | 37,662,091.00 | VIII. Earnings per share: | | | (i) Basic earnings per share | 0.98 | 1.10 | (ii) Diluted earnings per share | 0.98 | 1.10 |
Legal Representative: Wang Xiaodong
Person in charge of accounting works: Rong Bin Person in charge of accounting institute: Wu Junfei
2. Profit statement of parent company
In RMB
Item | 2023 semi-annual | 2022 semi-annual | I. Operating income | 1,999,983,446.71 | 2,411,189,208.04 | Less: Operating cost | 1,582,800,180.15 | 1,919,986,159.54 | Taxes and surcharge | 12,898,023.37 | 13,501,778.32 | Sales expenses | 14,804,263.68 | 14,392,542.42 | Administration expenses | 151,432,225.43 | 144,366,869.06 | R&D expenses | 121,018,486.34 | 115,694,064.37 | Financial expenses | -30,173,931.83 | -8,310,144.29 | Including: interest expenses | 46,417,119.10 | 18,380,946.47 | Interest income | 71,778,851.32 | 31,657,392.66 | Add: other income | 29,302,719.53 | 15,713,320.73 | Investment income (Loss is listed with “-”) | 711,673,709.71 | 835,209,662.03 | Including: Investment income on affiliated Company and joint
venture | 644,975,916.19 | 734,429,287.99 | The termination of income recognition for financial assets
measured by amortized cost (Loss is listed with “-”) | | | Net exposure hedging income (Loss is listed with “-”) | | | Changing income of fair value (Loss is listed with “-”) | -18,284,414.84 | -74,417,034.85 | Loss of credit impairment (Loss is listed with “-”) | -782,758.06 | 477,241.11 | Losses of devaluation of asset (Loss is listed with “-”) | -37,325,504.75 | -45,999,971.02 | Income on disposal of assets (Loss is listed with “-”) | 3,183,872.63 | 146,113.46 | II. Operating profit (Loss is listed with “-”) | 834,971,823.79 | 942,687,270.08 | Add: Non-operating income | 20,798.16 | 138,467.56 | Less: Non-operating expense | 452,082.96 | 613,619.53 | III. Total Profit (Loss is listed with “-”) | 834,540,538.99 | 942,212,118.11 | Less: Income tax | 20,717,315.23 | 33,033,489.65 | IV. Net profit (Net loss is listed with “-”) | 813,823,223.76 | 909,178,628.46 | (i) continuous operating net profit (net loss listed with ‘-”) | 813,823,223.76 | 909,178,628.46 | (ii) termination of net profit (net loss listed with ‘-”) | | | V. Net after-tax of other comprehensive income | | | (I) Other comprehensive income items which will not be reclassified
subsequently to profit of loss | | | 1. Changes of the defined benefit plans that re-measured | | | 2. Other comprehensive income under equity method that cannot be
transfer to gain/loss | | | 3. Change of fair value of other equity instrument investment | | | 4. Fair value change of enterprise's credit risk | | | 5. Other | | | (II) Other comprehensive income items which will be reclassified
subsequently to profit or loss | | | 1. Other comprehensive income under equity method that can
transfer to gain/loss | | | 2. Change of fair value of other debt investment | | | 3. Amount of financial assets re-classify to other comprehensive
income | | | 4. Credit impairment provision for other debt investment | | | 5. Cash flow hedging reserve | | | 6. Translation differences arising on translation of foreign currency
financial statements | | | 7. Other | | | VI. Total comprehensive income | 813,823,223.76 | 909,178,628.46 | VII. Earnings per share: | | | (i) Basic earnings per share | | | (ii) Diluted earnings per share | | |
3. Consolidated cash flow statement
In RMB
Item | 2023 semi-annual | 2022 semi-annual | I. Cash flows arising from operating activities: | | | Cash received from selling commodities and providing labor services | 7,220,274,822.77 | 7,278,359,413.36 | Net increase of customer deposit and interbank deposit | | | Net increase of loan from central bank | | | Net increase of capital borrowed from other financial institution | | | Cash received from original insurance contract fee | | | Net cash received from reinsurance business | | | Net increase of insured savings and investment | | | Cash received from interest, commission charge and commission | | | Net increase of capital borrowed | | | Net increase of returned business capital | | | Net cash received by agents in sale and purchase of securities | | | Write-back of tax received | 290,682,518.69 | 232,035,625.20 | Other cash received concerning operating activities | 350,434,811.67 | 1,276,954,478.94 | Subtotal of cash inflow arising from operating activities | 7,861,392,153.13 | 8,787,349,517.50 | Cash paid for purchasing commodities and receiving labor service | 5,293,150,104.57 | 5,605,274,974.42 | Net increase of customer loans and advances | | | Net increase of deposits in central bank and interbank | | | Cash paid for original insurance contract compensation | | | Net increase of capital lent | | | Cash paid for interest, commission charge and commission | | | Cash paid for bonus of guarantee slip | | | Cash paid to/for staff and workers | 845,487,116.19 | 736,897,874.74 | Taxe paid | 223,362,710.57 | 223,299,890.76 | Other cash paid concerning operating activities | 409,430,984.38 | 4,715,858,822.47 | Subtotal of cash outflow arising from operating activities | 6,771,430,915.71 | 11,281,331,562.39 | Net cash flows arising from operating activities | 1,089,961,237.42 | -2,493,982,044.89 | II. Cash flows arising from investing activities: | | | Cash received from recovering investment | 1,792,373,483.22 | 6,783,202,982.62 | Cash received from investment income | 227,184,527.61 | 510,529,403.51 | Net cash received from disposal of fixed, intangible and other long-
term assets | 130,808,256.39 | 7,007,242.74 | Net cash received from disposal of subsidiaries and other units | | | Other cash received concerning investing activities | | | Subtotal of cash inflow from investing activities | 2,150,366,267.22 | 7,300,739,628.87 | Cash paid for purchasing fixed, intangible and other long-term assets | 521,593,700.42 | 622,264,336.12 | Cash paid for investment | 1,384,532,499.32 | 5,121,895,293.87 | Net increase of mortgaged loans | | | Net cash received from subsidiaries and other units obtained | | | Other cash paid concerning investing activities | | | Subtotal of cash outflow from investing activities | 1,906,126,199.74 | 5,744,159,629.99 | Net cash flows arising from investing activities | 244,240,067.48 | 1,556,579,998.88 | III. Cash flows arising from financing activities | | | Cash received from absorbing investment | | | Including: Cash received from absorbing minority shareholders’
investment by subsidiaries | | | Cash received from loans | 2,472,142,881.63 | 4,061,893,674.46 | Other cash received concerning financing activities | | | Subtotal of cash inflow from financing activities | 2,472,142,881.63 | 4,061,893,674.46 | Cash paid for settling debts | 3,430,505,040.97 | 1,122,521,453.43 | Cash paid for dividend and profit distributing or interest paying | 150,449,335.07 | 1,499,815,013.36 | Including: Dividend and profit of minority shareholder paid by
subsidiaries | | 25,671,100.00 | Other cash paid concerning financing activities | 144,576,715.88 | 100,866,543.83 | Subtotal of cash outflow from financing activities | 3,725,531,091.92 | 2,723,203,010.62 | Net cash flows arising from financing activities | -1,253,388,210.29 | 1,338,690,663.84 | IV. Influence on cash and cash equivalents due to fluctuation in exchange
rate | 29,533,974.54 | -4,522,251.76 | V. Net increase of cash and cash equivalents | 110,347,069.15 | 396,766,366.07 | Add: Balance of cash and cash equivalents at the period -begin | 2,277,117,604.82 | 1,094,018,936.73 | VI. Balance of cash and cash equivalents at the period -end | 2,387,464,673.97 | 1,490,785,302.80 |
4. Cash flow statement of parent company (未完)
|
|